Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 12, 2014

OMAHA, Neb.--()--Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:

   
What: Transgenomic, Inc. Fourth Quarter 2013 Financial Results and Business Update Conference Call
 
When: Wednesday, March 12, 2014 @ 5:00 p.m. Eastern
 
Where:

http://www.videonewswire.com/event.asp?id=98380

 
How: Live over the Internet -- Simply log on to the web at the address above.
 
Contact: Investor Relations, 402-452-5416
 

To access the call via telephone, dial 866-952-1906 from the U.S. and Canada or 785-424-1825 for international participants and enter conference ID TRANS. A telephone replay will be available from 8:00 p.m. Eastern Time on March 12, 2014 through 11:59 p.m. Eastern Time on March 26, 2014 by dialing 800-677-7085 (domestic) or 402-220-0665 (international).

About Transgenomic, Inc.

Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases. The Company has three complementary business units: Patient Testing, Biomarker Identification, and Genetic Assays and Platforms, which provide specialized diagnostic tests, contract research services for drug development, and equipment, reagents and other consumables for clinical and research applications in molecular testing and cytogenetics.

Contacts

Investor Contact
Argot Partners
David Pitts, 212-600-1902
david@argotpartners.com
or
Company Contact
Transgenomic, Inc.
Donna Christian, 402-452-5416
investorrelations@transgenomic.com

Sharing

Contacts

Investor Contact
Argot Partners
David Pitts, 212-600-1902
david@argotpartners.com
or
Company Contact
Transgenomic, Inc.
Donna Christian, 402-452-5416
investorrelations@transgenomic.com